NCT02713113View on ClinicalTrials.gov

Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Bariatric Patients
Interventions
DRUG

sugammadex reversal of neuromuscular blockade

Trial Locations (1)

171516

South Egypt Cancer Instuite, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02713113 - Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery | Biotech Hunter | Biotech Hunter